title: Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant.
authors.affiliation: Pediatric Oncology, Children's Hospital of Philadelphia, and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104, USA. raplenc@cceb.med.upenn.edu
authors.forename: Richard
authors.initials: R
authors.lastname: Aplenc
authors.forename: Anil
authors.initials: A
authors.lastname: Vachani
authors.forename: Peggy
authors.initials: P
authors.lastname: Han
authors.forename: Wendy
authors.initials: W
authors.lastname: Glatfelter
authors.forename: Eric L
authors.initials: EL
authors.lastname: Sievers
mesh_terms: D000617:Aminoglycosides / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab; D018380:Hematopoietic Stem Cell Transplantation; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced*; D006801:Humans; D010597:Pharmacogenetics
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab